---
title: "培力农本方有限公司 (01498.HK)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/01498.HK.md"
symbol: "01498.HK"
name: "培力农本方有限公司"
industry: "制药"
---

# 培力农本方有限公司 (01498.HK)

| Item | Detail |
|------|--------|
| Industry | 制药 |
| Location | 港股市场 |
| Website | [www.purapharm.com](https://www.purapharm.com) |

## Company Profile

培力农本方有限公司 (原名：培力控股有限公司) 是一家主要从事浓缩中药配方颗粒产品业务的投资控股公司。该公司通过五个业务分部进行运营。中国浓缩中药配方颗粒分部在中国内地从事浓缩中药配方颗粒产品的生产及销售业务。香港浓缩中药配方颗粒分部主要在中国香港从事浓缩中药配方颗粒产品的销售业务，不包括通过自营诊所进行的销售。中药保健品分部主要在中国香港和中国内地等国家和地区从事保健品生产及销售业务。诊所分部主要提供中医门诊服务及通过自营诊所销售浓缩中药配方颗粒产品。种植分部主要从事中药材的种植及买卖，以及中药饮片的生产及销售。

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-20T04:30:10.000Z

**Overall: D (0.73)**

**Industry**: Pharmaceuticals

| Metric | Value |
|--------|-------|
| Industry Ranking | 45 / 48 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -17.32% |  |
| Net Profit YoY | 55.73% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | 1.77 |  |
| Dividend Ratio | 0.00% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 179.53M |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 346.76M |  |


**Multi Score**: D

#### Profit Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -33.22% | E |
| Profit Margin | -11.12% | D |
| Gross Margin | 55.21% | B |

#### Growth Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -17.32% | E |
| Net Profit YoY | 55.73% | B |
| Total Assets YoY | -13.17% | E |
| Net Assets YoY | -22.09% | E |

#### Cash Score: E

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | -899.29% | E |
| OCF YoY | -17.32% | E |

#### Operating Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 0.47 | C |

#### Debt Score: E

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 85.02% | E |


```chart-data:radar
{
  "title": "Longbridge Financial Score - 培力农本方有限公司",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "D",
      "indicators": [
        {
          "name": "ROE",
          "value": "-33.22%",
          "rating": "E"
        },
        {
          "name": "Profit Margin",
          "value": "-11.12%",
          "rating": "D"
        },
        {
          "name": "Gross Margin",
          "value": "55.21%",
          "rating": "B"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "D",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-17.32%",
          "rating": "E"
        },
        {
          "name": "Net Profit YoY",
          "value": "55.73%",
          "rating": "B"
        },
        {
          "name": "Total Assets YoY",
          "value": "-13.17%",
          "rating": "E"
        },
        {
          "name": "Net Assets YoY",
          "value": "-22.09%",
          "rating": "E"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "E",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "-899.29%",
          "rating": "E"
        },
        {
          "name": "OCF YoY",
          "value": "-17.32%",
          "rating": "E"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "C",
      "indicators": [
        {
          "name": "Turnover",
          "value": "0.47",
          "rating": "C"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "E",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "85.02%",
          "rating": "E"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | 恒瑞医药 (HK.1276) | A | B | C | A | B | B |
| 02 | 翰森制药 (HK.3692) | A | B | C | A | C | B |
| 03 | 中国生物制药 (HK.1177) | B | B | C | B | B | B |
| 04 | 康哲药业 (HK.867) | B | B | C | A | B | B |
| 05 | 先声药业 (HK.2096) | B | B | B | C | B | B |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -4.66 | 39/51 | - | - | - |
| PB | 1.77 | 30/51 | 1.85 | 1.74 | 1.67 |
| PS (TTM) | 0.52 | 5/51 | 0.55 | 0.51 | 0.49 |
| Dividend Yield | 0.00% | - | - | - | - |

## References

- [Company Overview](https://longbridge.com/en/quote/01498.HK/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/01498.HK/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/01498.HK/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.
